VIO Chemicals awarded with European Commission’s Seal of Excellence

23 May 2019

The European Commission has recently awarded VIO Chemicals with the Seal of Excellence, a high-quality label for first-class innovation ideas worthy of investment.

With this award the European Commission recognizes VIO Chemicals as a highly innovative enterprise with clear potential to compete internationally in high-growth markets.

VIO Chemicals awarded with European Commission’s Seal of Excellence

“For us at VIO Chemicals, it is an honour to have our efforts recognized. The recognition is more fulfilling as it comes by an international panel of independent experts in a highly competitive evaluation process in terms of excellence, impact, quality and efficiency of implementation”, commented VIO Chemicals CEO and founder, Dimitris Kalias.

“We are very proud that our project scored highly against nearly 3,000 applicants and this award reinforces our commitment to integrating innovation as a value and approach in all of our work”.

The Seal of Excellence is the Certificate of high quality awarded to projects submitted to Horizon 2020 Programme, which have passed all the stringent selection and award criteria but could not get funded due to Horizon 2020 budget limits. The “Seal” identifies the business value of the VIO Chemicals proposal and merits funding from alternative sources, public, private, national, regional European or international.

Read More

Related news

GSK partners with Samsung Biologics to secure additional manufacturing capacity

GSK partners with Samsung Biologics to secure additional manufacturing capacity

26 May 2020

The agreement will initially cover the commercial production of Benlysta (belimumab) with the intention to expand to additional specialty-care products in the future.

Read more 
Changes needed to prevent controversial pay-for-delay pharma deals

Changes needed to prevent controversial pay-for-delay pharma deals

26 May 2020

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Read more 
SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

26 May 2020

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Read more 
AbCellera and Lilly seal multi-year antibody discovery collaboration

AbCellera and Lilly seal multi-year antibody discovery collaboration

25 May 2020

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

Read more 
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

25 May 2020

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

Read more 
Can the industry really claim it's 'business as usual'?

Can the industry really claim it's 'business as usual'?

19 May 2020

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Read more 
HKBU scientists develop technique to eliminate drug side effects

HKBU scientists develop technique to eliminate drug side effects

19 May 2020

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

Read more 
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

19 May 2020

The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.

Read more 
Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

18 May 2020

CDMO is contracted to produce multiple clinical batches from German facility

Read more 
Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more